Toward Small-Molecule Inhibition of Protein-Protein Interactions: General Aspects and Recent Progress in Targeting Costimulatory and Coinhibitory (Immune Checkpoint) Interactions

Current Topics in Medicinal Chemistry
Damir Bojadzic, Peter Buchwald

Abstract

Protein-Protein Interactions (PPIs) that are part of the costimulatory and coinhibitory (immune checkpoint) signaling are critical for adequate T cell response and are important therapeutic targets for immunomodulation. Biologics targeting them have already achieved considerable clinical success in the treatment of autoimmune diseases or transplant recipients (e.g., abatacept, belatacept, and belimumab) as well as cancer (e.g., ipilimumab, nivolumab, pembrolizumab, atezolizumab, durvalumab, and avelumab). In view of such progress, there have been only relatively limited efforts toward developing small-molecule PPI inhibitors (SMPPIIs) targeting these cosignaling interactions, possibly because they, as all other PPIs, are difficult to target by small molecules and were not considered druggable. Nevertheless, substantial progress has been achieved during the last decade. SMPPIIs proving the feasibility of such approaches have been identified through various strategies for a number of cosignaling interactions including CD40-CD40L, OX40-OX40L, BAFFR-BAFF, CD80-CD28, and PD-1-PD-L1s. Here, after an overview of the general aspects and challenges of SMPPII-focused drug discovery, we review them briefly together with relevant structura...Continue Reading

Citations

May 28, 2020·International Journal of Molecular Sciences·Eun-Hye KimHideyuki Miyatake
Jun 21, 2020·Biology of Reproduction·Daniel S Johnston, Erwin Goldberg
Aug 4, 2020·Journal of Leukocyte Biology·Chloe M McKee, Rebecca C Coll
May 13, 2018·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Damir BojadzicPeter Buchwald
Sep 11, 2019·Diabetologia·Damir Bojadzic, Peter Buchwald
Mar 11, 2020·Nature Chemical Biology·Tianshu XiaoBing Chen
Oct 4, 2020·Diabetes & Metabolism·Natalie YoussefAssaad A Eid
Jan 13, 2021·International Journal of Molecular Sciences·Serena VittorioLaura De Luca
Mar 3, 2021·Chemical Communications : Chem Comm·Marijn N MaasJasmin Mecinović
Nov 30, 2019·Molecular Therapy : the Journal of the American Society of Gene Therapy·Jamie L ShirleyRoland W Herzog
Apr 26, 2021·Pharmacology & Therapeutics·Mohammad Kaisarul Islam, Johnson Stanslas
Jun 29, 2021·Frontiers in Oncology·María Paz SaldíasOscar Cerda
Aug 5, 2021·Nature Communications·Alexander BolaenderGabriela Chiosis
Nov 12, 2020·Journal of Medicinal Chemistry·Celeste N AlverezKyung S Lee
Oct 1, 2021·Chemical Society Reviews·Jana VolarićBen L Feringa

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.

Cell Checkpoints & Regulators

Cell cycle checkpoints are a series of complex checkpoint mechanisms that detect DNA abnormalities and ensure that DNA replication and repair are complete before cell division. They are primarily regulated by cyclins, cyclin-dependent kinases, and the anaphase-promoting complex/cyclosome. Here is the latest research.